Evidence map›Paper›PMID 30180166›Full record

ArticlePLoS genetics2018

Epistatic control of intrinsic resistance by virulence genes in Listeria.

Mariela Scortti, Lei Han, Sonsiray Alvarez, Alexandre Leclercq, Alexandra Moura, Marc Lecuit, Jose Vazquez-Boland

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Predicting Antibiotic Resistance inInternational journal of molecular sciences · 2025
    Pooled it
  2. Article
  3. Molecular Characterization ofInternational journal of women's health · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Listeriosis.Nature reviews. Disease primers · 2025
    Review
  9. Genomic characterization ofMicrobial genomics · 2025
    Article
  10. Article
  11. Review
  12. Phenotypic and genotypic antimicrobial resistance ofThe Lancet regional health. Europe · 2024
    Article
  13. Review
  14. Genomic Characterization ofPathogens (Basel, Switzerland) · 2023
    Article
  15. Article
  16. Human Listeriosis.Clinical microbiology reviews · 2023
    Review
  17. Genetic Characterization ofFoods (Basel, Switzerland) · 2023
    Article
  18. Review
  19. Whole-genome sequencing ofFrontiers in microbiology · 2023
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Mariela ScorttiMicrobial Pathogenesis Group, Division of Infection Medicine, Edinburgh Medical School (Biomedical Sciences), University of Edinburgh, Little France campus, Edinburgh, United Kingdom.
Lei HanMicrobial Pathogenesis Group, Division of Infection Medicine, Edinburgh Medical School (Biomedical Sciences), University of Edinburgh, Little France campus, Edinburgh, United Kingdom.
Sonsiray AlvarezMicrobial Pathogenesis Group, Division of Infection Medicine, Edinburgh Medical School (Biomedical Sciences), University of Edinburgh, Little France campus, Edinburgh, United Kingdom.
Alexandre LeclercqInstitut Pasteur, Biology of Infection Unit, INSERM U111 and National Reference Centre / WHO Collaborating Centre for Listeria, Paris, France.ORCID 0000-0003-3778-7313
Alexandra MouraInstitut Pasteur, Biology of Infection Unit, INSERM U111 and National Reference Centre / WHO Collaborating Centre for Listeria, Paris, France.ORCID 0000-0003-0339-1230
Marc LecuitInstitut Pasteur, Biology of Infection Unit, INSERM U111 and National Reference Centre / WHO Collaborating Centre for Listeria, Paris, France.ORCID 0000-0002-4491-1063
Jose Vazquez-BolandMicrobial Pathogenesis Group, Division of Infection Medicine, Edinburgh Medical School (Biomedical Sciences), University of Edinburgh, Little France campus, Edinburgh, United Kingdom.ORCID 0000-0003-4521-5972
Inserm · FRRoslin Institute · GBUniversity of Edinburgh · GB

Funding

Biotechnology and Biological Sciences Research Council BB/J004227/1Wellcome TrustWellcome Trust WT074020MA
6 · The paper itself

Abstract

Elucidating the relationships between antimicrobial resistance and virulence is key to understanding the evolution and population dynamics of resistant pathogens. Here, we show that the susceptibility of the gram-positive bacterium Listeria monocytogenes to the antibiotic fosfomycin is a complex trait involving interactions between resistance and virulence genes and the environment. We found that a FosX enzyme encoded in the listerial core genome confers intrinsic fosfomycin resistance to both pathogenic and non-pathogenic Listeria spp. However, in the genomic context of the pathogenic L. monocytogenes, FosX-mediated resistance is epistatically suppressed by two members of the PrfA virulence regulon, hpt and prfA, which upon activation by host signals induce increased fosfomycin influx into the bacterial cell. Consequently, in infection conditions, most L. monocytogenes isolates become susceptible to fosfomycin despite possessing a gene that confers high-level resistance to the drug. Our study establishes the molecular basis of an epistatic interaction between virulence and resistance genes controlling bacterial susceptibility to an antibiotic. The reported findings provide the rationale for the introduction of fosfomycin in the treatment of Listeria infections even though these bacteria are intrinsically resistant to the antibiotic in vitro.

Indexed as

Anti-Bacterial AgentsBacterial ProteinsDrug Resistance, BacterialEpistasis, GeneticFosfomycinGene Expression Regulation, BacterialGlutathione TransferaseListeria monocytogenesListeriosisMembrane Transport ProteinsPeptide Termination FactorsRegulonVirulenceAnti-Bacterial AgentsBacterial ProteinsFosfomycinGlutathione TransferaseHpt permease, Listeria monocytogenesMembrane Transport ProteinsPeptide Termination FactorsPrfA protein, Listeria monocytogenes

Identifiers

PMID30180166
PMCPMC6122793
OpenAlexW2891459495

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.